Key references
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.pdf -
A reappraisal of loop diuretic choice in heart failure patients Review 2015.pdf
-
A Tale of Coronary Artery Disease and Myocardial Infarction.pdf
-
ACC 2012 Expert Consensus Document on Troponin Elevations.pdf
-
ACC:AHA Coronary Revascularization in Patients With Acute Coronary Syndromes 2016.pdf.pdf
-
ACC:AHA Guidelines Infective Endocarditis in Adults 2015.pdf
-
ACC:AHA Guidelines Management of adults with congenital heart disease.pdf
-
ACC:AHA Guidelines Management of intracerebral hemorrhage.pdf
-
ACC:AHA Guidelines Perioperative evaluation and care for non cardiac surgery.pdf
-
ACC:AHA Guidelines Unstable angina non-ST elevation MI 2007.pdf
-
ACCF:AHA 2013 Guideline for the Management of ST-Elevation Myocardial Infarction.pdf
-
ACCF:AHA Guideline for the Management of Heart Failure 2013.pdf
-
ACCP thrombosis 9th ed Antithrombotic and Thrombolytic Therapy for Ischemic Stroke.pdf
-
ACCP thrombosis 9th ed Antithrombotic Therapy for Atrial Fibrillation.pdf
-
ACCP thrombosis 9th ed Antithrombotic Therapy in Peripheral Artery Disease.pdf
-
ACCP thrombosis 9th ed Evidence-Based Management of Anticoagulant Therapy.pdf
-
ACCP thrombosis 9th ed Perioperative Management of Antithrombotic Therapy.pdf
-
ACCP thrombosis 9th ed Prevention of VTE in Nonorthopedic Surgical Patients.pdf
-
ACCP thrombosis 9th ed Prevention of VTE in Nonsurgical Patients.pdf
-
ACCP thrombosis 9th ed Prevention of VTE in Orthopedic Surgery Patients.pdf
-
ACCP thrombosis 9th ed Primary and Secondary Prevention of Cardiovascular Disease.pdf
-
ACCP thrombosis 9th ed Treatment and Prevention of Heparin-Induced Thrombocytopenia.pdf
-
ACCP thrombosis 9th ed VTE Antithrombotic Therapy for VTE Disease.pdf
-
ACCP thrombosis 9th ed VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy.pdf
-
Acetazolamide for Obstructive and Central Sleep Apnea 2020.pdf
-
Acetyl Cysteine importance of dose and route of administration.pdf
-
Acquisition of Antibiotic-Resistant Bacteria by U.S. International Travelers.pdf
-
Acute alcohol toxicity and withdrawal in the emergency room and medical admissions unit.pdf
-
Acute Exacerbation of Idiopathic Pulmonary Fibrosis Review.pdf
-
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes Review 2014.pdf
-
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection 2018.pdf
-
Acute Myocardial Infarction and Left Bundle-Branch Block -- Can We Lift the Veil.pdf
-
acute pneumonia and the cardiovascular system review 2013.pdf
-
Acute renal failure an unacceptable death sentence globally.pdf
-
Air Versus Oxygen in ST-Segment–Elevation Myocardial Infarction.pdf
-
An alarming rise in incidence of infective endocarditis in England since 2009.pdf
-
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure.pdf
-
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.pdf
-
Ankle-brachila index for assessment of peripheral arterial disease.pdf
-
Answers to Common Questions About the Use and Safety of CT Scans.pdf
-
Antiplatelet strategies in ageing patients with acute coronary syndromes.pdf
-
Antiplatelet therapy after coronary stenting for how long.pdf
-
Atheroma in soldiers autopsied from Korean, Viet Nam and Iraq War.pdf
-
Avoidance of high concentration oxygen in chronic obstructive pulmonary disease copy.pdf
-
B-Natriuretic Peptide in Detecting Diastolic Dysfunction.pdf
-
BNP a useful tool for the detection of acute pulmonary artery embolism.pdf
-
BNP and troponin in risk stratification in pulmonary embolism review.pdf
-
BTS guidelines for the management of malignant pleural effusions.pdf
-
Cardiac Drugs-Antithrombotic agents Platelet inhibitors acute anticoagulants fibrinolytics.pdf
-
Cardiac Drugs-Lipid modifying and antiatherosclerotic drugs.pdf
-
Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease Review 2016.pdf
-
Cardiac Failure, Kidney Dysfunction, and Kidney Injury Intersect in Cardiorenal Syndrome.pdf
-
Cardiac Resynchronization Therapy for Treatment of Heart Failure.pdf
-
Cardiovascular remodelling in coronary artery disease and heart failure review 2014.pdf
-
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis Review 2017.pdf
-
Cirrhosis in HCV: Fibroscan, King's Score and Liver Biopsy.pdf
-
Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy.pdf
-
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.pdf
-
Clinical features of patients infected with 2019 novel coronavirus in Wuhan 2020.pdf
-
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk 2019.pdf
-
Contrast CT Scans in the Emergency Department Do Not Increase Risk of Adverse Renal Outcomes.pdf
-
Contrast Induced Nephropathy - distal Ischemic Preconditioning for Prevention.pdf
-
Contrast-induced nephropathy following angiography and cardiac interventions.pdf
-
Contribution of External Forces to Left Ventricular Diastolic Pressure.pdf
-
Could a New Method to Detect Coronary Inflammation Prevent Heart Attacks?.pdf
-
Determinants of the decline in mortality from acute myocardial infarction in England.pdf
-
Detrimental role of humoral signalling in cardio-renal cross-talk.pdf
-
Diagnosis and Management of Heart Failure with Preserved Ejection Fraction 10 Key Lessons.pdf
-
Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury guidelines 2014.pdf
-
Diagnosis of Tuberculosis in Adults and Children guideline 2016.pdf
-
Do natruiuretic peptides have a role in chronic renal failure.pdf
-
Does hemofiltration protect against contrast induced renal failure?.pdf
-
Dual antiplatelet therapy post CABG?why not a radial artery instead?.pdf
-
Early Surgery versus Conventional Treatment for Infective Endocarditis.pdf
-
Effect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality.pdf
-
Epidemiology, Antibiotic Therapy, and Clinical Outcomes in Health Care–Associated Pneumonia.pdf
-
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.pdf
-
ESC Guidelines for the management of infective endocarditis 2015.pdf
-
Estimating the Risk of Radiocontrast-Associated Nephropathy.pdf
-
Evaluation and Initial Treatment of Supraventricular Tachycardia.pdf
-
Evaluation of Patients With Suspected Acute Pulmonary embolism.pdf
-
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure.pdf
-
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis.pdf
-
Fluid removal in acute heart failure diuretics versus devices Review 2014.pdf
-
Guidelines for management of catheter associated urinary tract infections.pdf
-
Guidelines for the Early Management of Patients With Acute Ischemic Stroke 2013.pdf
-
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage 2015.pdf
-
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage.pdf
-
Heart failure and chronic obstructive pulmonary disease Review.pdf
-
Heart Failure With Preserved Ejection Fraction A Kidney Disorder.pdf
-
Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease.pdf
-
Hemofiltration and contrast induced renal failure letter.pdf
-
How Big Are Coronary Atherosclerotic Plaques That Rupture.pdf
-
Imaging of coronary inflammation for cardiovascular risk prediction.pdf
-
Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction.pdf
-
Imported Malaria in Countries where Malaria Is Not Endemic.pdf
-
Increased Central Venous Pressure Is Associated With Impaired Renal Function.pdf
-
Infections of Cardiovascular Implantable Electronic Devices review 2012.pdf
-
Inflammation as a Treatment Target after Acute Myocardial Infarction 2019.pdf
-
Influenza update 2018–2019 100 years after the great pandemic.pdf
-
Inhaled and intravenous treatment in acute severe and life threatening asthma review 2012.pdf
-
Interpretation of Abnormal Liver Chemistries in the Hospitalized Patient.pdf
-
Interstitial Lung Disease and Pulmonary Fibrosis Review 2018.pdf
-
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.pdf
-
Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants Review 2017.pdf
-
Management of acute upper gastrointestinal bleeding Review 2019.pdf
-
Management of the Cardiorenal Syndrome in Decompensated Heart Failure Reveiw 2014.pdf
-
Medical and Surgical Treatment of Parapneumonic Effusions.pdf
-
Meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity.pdf
-
Mode of Death in Heart Failure With Preserved Ejection Fraction.pdf
-
Mountain sickness, retinal haemorrhages and acclimatisation on Mount Everest in 1975.pdf
-
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia.pdf
-
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure.pdf
-
Novel coronavirus infection during the 2019–2020 epidemic preparing intensive care units.pdf
-
NSAIDs for high-risk patients none, celecoxib, or naproxen?.pdf
-
Oral antiplatelet and anticoagulant treatments Review 2015.pdf
-
Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine 2018.pdf
-
Pathology of Drug Eluting Stents in Humans Delayed Healing and Late Thrombotic Risk.pdf
-
Pathophysiology of ST-segment elevation myocardial infarction.pdf
-
Pentoxifylline for the treatment of severe alcoholic hepatitis.pdf
-
Platelet Activation Is Associated With Myocardial Infarction in Patients With Pneumonia.pdf
-
Practical guidance on the use of sacubitril:valsartan for heart failure.pdf
-
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization.pdf
-
Predicting 30-Day Mortality for Patients With Acute Heart Failure.pdf
-
Prediction of severe community acquired pneumonia review 2012.pdf
-
Prevalence of Pulmonary Embolism in Acute Exacerbations of COPD.pdf
-
Preventative measures for contrast induced acute renal failure review.pdf
-
Preventing Heart Failure and Improving Survival with CRT.pdf
-
Preventing major gastrointestinal bleeding in elderly patients.pdf
-
Prolonged antiplatelet therapy after drug-eluting stents.pdf
-
Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer.pdf
-
Protective Cardiovascular Effect of Sleep Apnea Severity in Obesity Hypoventilation Syndrome.pdf
-
Protocol for the prevention of contrast-induced renal dysfunction.pdf
-
Redefining Heart Failure With a Reduced Ejection Fraction.pdf
-
Relationship between QRS duration and LV mass and volume.pdf
-
Remote Ischemic Preconditioning for Intestinal and Pulmonary Protection .pdf
-
Remote Ischemic Preconditioning Protects the spinal cord.pdf
-
Serelaxin recombinant human relaxin for treatment of acute heart failure.pdf
-
Simple pharmacological prophylaxis for post-ERCP pancreatitis.pdf
-
Society’s failure to protect a precious resource antibiotics.pdf
-
Stent thrombosis and restenosis The Andreas Gruntzig Lecture.pdf
-
Survival with Cardiac-Resynchronization Therapy in Mild Heart Failure.pdf
-
The broken promise of remote ischaemic conditioning 2019.pdf
-
The case of digoxin in atrial fibrillation and heart failure.pdf
-
The cost to the CNS of climbing to extremely high altitudes-Hornbein.pdf
-
The diagnostic accuracy of the natriuretic peptides in heart failure.pdf
-
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure.pdf
-
The Effect of Renal Dysfunction on BNP, NT-ProBNP, and Their Ratio.pdf
-
The potential harm of oxygen therapy in medical emergencies.pdf
-
Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents.pdf
-
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.pdf
-
Timing of Antibiotics and Outcomes for Patients Hospitalized With Community Acquired Pneumonia.pdf
-
Timing of Intervention in Non-ST Elevation Acute Coronary Syndromes.pdf
-
Transcatheter aortic valve replacement: Indications and periprocedural management.pdf
-
Transcatheter Aortic-Valve Replacement with a Balloon- Expandable Valve in Low-Risk Patients.pdf
-
Transfusion after acute upper gastrointestinal haemorrhage.pdf
-
Treatment associated inflammatory deterioration in tuberculous meningitis.pdf
-
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis.pdf
-
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.pdf
-
Upper Gastrointestinal Bleeding Due to a Peptic Ulcer review 2016.pdf
-
Vascular access and antithrombotic therapy in patients with acute coronary syndrome.pdf
-
Venous thromboembolism prophylaxis may cause more harm than benefit.pdf
-
Von Willebrand Factor — A Rapid Sensor of Paravalvular Regurgitation during TAVR.pdf
-
What to do now in Heart Failure with Preserved Ejection Fraction.pdf
-
What’s new in the Fourth Universal Definition of Myocardial infarction?.pdf
